Moreover, according to the latest American Thyroid Association (ATA) 2015 guidelines, familial medullary thyroid carcinoma (FMTC) is recognized as a variant of MEN2A with reduced penetrance of hyperparathyroidism and pheochromocytoma [12,14]. This evidence concerns the gene RET and hereditary pheochromocytoma-paraganglioma.